APPLICATION
ANDA075552
TYPE
ANDA
ORIGINAL APPROVAL
2003-03-31
LATEST ACTION
2003-03-31
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Discontinued
Products
IPRATROPIUM BROMIDEDiscontinued
IPRATROPIUM BROMIDE 0.021MG/SPRAY · SPRAY, METERED · NASAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.